IP Library Granted Patent US 12,351,621
Granted Patent B1
US 12,351,621 · App. 18/935,626 · Granted Jul 8, 2025

Composite collagen product and method of making thereof

Inventor: Mohammad Z. Albanna (Chandler, AZ)
Assignee: Humabiologics, Inc.
C07K14/78
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,351,621
App. No.
18/935,626
Granted
Jul 8, 2025
Kind
B1
Abstract

A process for the production of a soluble collagen product and an insoluble collagen product from mammalian dermis tissue is described. The tissue may initially be processed to remove the epidermis and adipose tissue and then minced into small pieces. The process includes washing the minced dermis in an enzymatic solution, such as an amylase solution followed by homogenizing the amylased tissue. The soluble and insoluble collagen is then extracted from the homogenized tissue and subsequently separated into distinct soluble and insoluble fractions. The process produces collagen with high Dalton values that can subsequently be combined to produce a mixed composite collagen product. Also, the extracted collagen may be used as an integral composite collagen before separation.

Claims (17)

1. A manufactured composite collagen product comprising:

a) a soluble collagen component; and

b) an insoluble collagen component;

wherein the soluble collagen component is configured in the composite collagen product at a ratio to insoluble collagen component;

wherein the composite collagen is a sheet of collagen;

wherein the sheet of collagen is a membrane having has a thickness of 1 mm or less;

wherein the sheet of collagen comprises a plurality of sheets of collagen bonded together;

wherein the composite collagen has a first laver of composite collagen with a first ratio of soluble collagen component to insoluble collagen component and a second laver of composite collagen with a second ratio of soluble collagen component to insoluble collagen component, and wherein the first ratio of soluble collagen component to insoluble collagen component is between 0.25:1 and 1.75:1 and at least 25% greater than the second ratio of soluble collagen component to insoluble collagen component; and

wherein the first layer is configured on a first surface of the composite collagen product and wherein the second layer is configured on a second surface of the composite collagen product, wherein the second layer is opposite the first layer.

2. The composite collagen product of claim 1 , wherein sheet of collagen further comprises an additive and wherein the additive comprises elastin.

3. The composite collagen product of claim 1 , wherein the composite collagen product is configured into a tube.

4. The composite collagen product of claim 1 , further comprising an additive and wherein the additive in an integral additive comprising collagen fibers that is mixed with the composite collagen product.

5. The composite collagen product of claim 1 , wherein the additive in an additive sheet selected from the group consisting of elastin and dermis bioresorbable material.

6. The composite collagen product of claim 5 , wherein the additive sheet extends on a surface of the composite collagen product.

7. The composite collagen product of claim 5 , wherein the additive sheet is configured between layers of composite collagen product.

8. The composite collagen product of claim 1 , wherein the additive in an additive tube selected from the group consisting of elastin and dermis bioresorbable material.

9. The composite collagen product of claim 1 , wherein the additive is a collagen fiber.

Continuity (2)
Continuation In Part 18654723 · May 3, 2024
Provisional Application 63463579 · May 3, 2023
References Cited (14)
US 4784986A · Usher · 1988 [cited by applicant]
US 4969912A · Kelman et al. · 1990 [cited by applicant]
US 5677284A · Li · 1997 [cited by applicant]
US 5980946A · Jones et al. · 1999 [cited by applicant]
US 6936271B1 · Oliver et al. · 2005 [cited by applicant]
US 10709810B2 · Sun et al. · 2020 [cited by applicant]
US 10821205B2 · Xu et al. · 2020 [cited by applicant]
US 20070014773A1 · Matheny et al. · 2007 [cited by applicant]
US 20150313623A1 · Bellomo et al. · 2015 [cited by applicant]
US 20190247287A1 · Pinsky · 2019 [cited by applicant]
US 20190351097A1 · Voytik-Harbin · 2019 [cited by applicant]
US 20200093799A1 · Dreher · 2020 [cited by applicant]
US 20220168105A1 · Agnello · 2022 [cited by examiner]
WO 2021210639 · 2021 [cited by examiner]